Neurology

From stroke to neurodegeneration — the science and its clinical impact.

eMTBR-Tau Webinar Explores Blood Biomarkers in Alzheimer’s Disease

A Fierce Biotech webinar will explore eMTBR-Tau as a blood biomarker for tau aggregation, PET staging, and progression in Alzheimer’s disease.

Siemens Healthineers and Paradromics are developing multimodal imaging tools to improve brain-computer interface planning, placement and follow-up.

A repeated-measures study in subacute spinal cord injury found abdominal FES with a binder best preserved upright mean…

A Cureus study compared seven AI-generated stroke driving leaflets with the Stroke Association version, finding readability gains but…

Overactive brain immune cells, not plaque clearance, restored more than two hours of sleep in an Alzheimer’s study…

A community survey in Cachar district found substantial stroke burden, disability, and care gaps in tea-tribe residents, plus…

A Finnish randomized trial will test whether a 10-week music-based telerehabilitation program improves speech, movement, mood, and brain…

Three scientists won the 2026 Nobel Prize for optogenetics, a light-based method that lets researchers switch brain cells…

A long-term study links as few as 3,000 daily steps to slower tau buildup and less cognitive decline…

A Columbia study identifies how excess fibronectin disrupts the blood-brain barrier in APOE ε4 carriers and points to…

Neurology

From stroke to neurodegeneration — the science and its clinical impact.

In Brief The 5-minute rounds